GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 39 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 34.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,110,000 | +263.9% | 232,172 | +163.1% | 0.01% | +50.0% |
Q1 2020 | $305,000 | -41.9% | 88,243 | -2.8% | 0.01% | -38.5% |
Q4 2019 | $525,000 | +51.3% | 90,748 | +25.0% | 0.01% | +62.5% |
Q3 2019 | $347,000 | -22.5% | 72,595 | +19.1% | 0.01% | -27.3% |
Q2 2019 | $448,000 | +2.1% | 60,948 | +13.4% | 0.01% | -15.4% |
Q1 2019 | $439,000 | +57.3% | 53,749 | +31.6% | 0.01% | +18.2% |
Q4 2018 | $279,000 | -42.7% | 40,844 | +13.9% | 0.01% | -26.7% |
Q3 2018 | $487,000 | – | 35,846 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|